Fujifilm’s legacy and history
First steps in the development of X-ray.
Though often perceived as a film and photography company, Fujifilm developed from its very beginning as a medical imaging specialist.
Innovation in diagnostic imaging
Our first steps in the development of X-ray film in 1936, and later advances in imaging film and archiving film, set the course for a long line of breakthrough technologies.
The 1980s saw the digital revolution break new ground, bringing a fundamental change in the transmission and sharing of data; Fujifilm developed the world’s first digital X-ray system, bringing new speeds and efficiencies, and achieving wider availability for patients, along with reductions in operational costs.
Toward the end of the 20th century the Internet was born, along with the emergence of dynamic networks, informatics and the management and sharing of data across systems. Fujifilm introduced Synapse® to the market in 1999, combining the revolution in information technology with the networking of diagnostic imaging systems.
Entry into pharmaceutical therapies
The 21st century heralds a new era in pharmacology and we are taking major steps to become a comprehensive healthcare company, adding this integral capability to our portfolio. In 2008, Fujifilm acquired Toyama Chemical, bringing strong expertise in the research and development of drugs to fight infectious and neurological diseases.
All of these diagnostic and therapeutic technologies form a highly connected and holistic approach to healthcare, with the goal of helping patients along the entire care pathway, from the earliest diagnosis right through to the development of new regenerative treatments.
Fuji Computed Radiology (FCR), the first digital radiography system in the world, was released in 1983. FCR was developed through Fujifilm’s pioneering technology in a new field, leading to widespread digitization of radiography as well as creating the foundation for advanced 3D imaging applications and lower radiation dose.